GUTS insider transaction filings

FRACTYL HEALTH, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-16. Screen GUTS transaction legs live →

Insider transaction summary — last 90 days

2026-06-24 to 2026-09-22, from the filings listed below: 1 Form 4 filing. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
BRADLEY WILLIAM — Director11 leg · 64,516 sh · $39,903

Recent Form 4 filings — FRACTYL HEALTH, INC.

FiledFormInsiderReported transactionsSource
2026-09-164BRADLEY WILLIAM — DirectorPurchase (P): 64,516 @ $0.62EDGAR
2026-06-154Royan Ajay — DirectorPurchase (P): 23,000 @ $0.85EDGAR
2026-06-114Conaway Samuel — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2026-06-114Royan Ajay — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2026-06-114Thompson Christopher Charles — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2026-06-114Elia Marc — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2026-06-114Barnes Kelly Ann — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2026-06-114Sheffield Ian — DirectorPurchase (P): 35,000 @ $0.73 · Grant/award (A): 22,500 (derivative) @ $0EDGAR
2026-06-114Rajagopalan Harith — Chief Executive Officer, DirectorPurchase (P): 25,000 @ $0.73EDGAR
2026-06-114MEANWELL CLIVE — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2026-06-114BRADLEY WILLIAM — DirectorPurchase (P): 68,493 @ $0.73 · Grant/award (A): 22,500 (derivative) @ $0EDGAR
2026-06-094Smith Weber Lara — Chief Financial OfficerPurchase (P): 20,000 @ $0.69EDGAR
2026-01-144Smith Weber Lara — Chief Financial OfficerGrant/award (A): 1,036,800 (derivative) @ $0EDGAR
2025-12-174Toomey Sarah — General CounselGrant/award (A): 743,913 (derivative) @ $0EDGAR
2025-12-174Rajagopalan Harith — Chief Executive Officer, DirectorGrant/award (A): 2,486,302 (derivative) @ $0EDGAR
2025-12-174Caplan Jay David — President, Chief Product Off.Grant/award (A): 845,226 (derivative) @ $0EDGAR
2025-12-084Rajagopalan Harith — Chief Executive Officer, DirectorPurchase (P): 10,416 @ $1.92EDGAR
2025-09-044Thompson Christopher Charles — DirectorGrant/award (A): 45,000 (derivative) @ $0EDGAR
2025-09-044Sheffield Ian — DirectorGrant/award (A): 45,000 (derivative) @ $0EDGAR
2025-06-134Elia Marc — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2025-06-134Barnes Kelly Ann — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2025-06-134Conaway Samuel — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2025-06-134Royan Ajay — Director, 10% ownerGrant/award (A): 22,500 (derivative) @ $0EDGAR
2025-06-134SCHULMAN AMY W — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2025-06-134MEANWELL CLIVE — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2025-06-134BRADLEY WILLIAM — DirectorGrant/award (A): 22,500 (derivative) @ $0EDGAR
2025-03-184Royan Ajay — Director, 10% ownerPurchase (P): 17,901 @ $1.28EDGAR
2025-03-184Barnes Kelly Ann — DirectorPurchase (P): 31,000 @ $1.30EDGAR
2025-03-184/AConaway Samuel — DirectorHoldings only — no transactions reportedEDGAR
2025-03-174Conaway Samuel — DirectorPurchase (P): 8,550 @ $1.17EDGAR
2025-03-174SCHULMAN AMY W — DirectorPurchase (P): 8,550 @ $1.17EDGAR
2025-03-174BRADLEY WILLIAM — DirectorPurchase (P): 16,129 @ $1.26EDGAR
2025-03-034Kieffer Timothy — Chief Scientific OfficerGrant/award (A): 169,700 (derivative) @ $0 · Grant/award (A): 35,280 (derivative) @ $0EDGAR
2025-03-034Toomey Sarah — General CounselGrant/award (A): 166,200 (derivative) @ $0 · Grant/award (A): 79,380 (derivative) @ $0EDGAR
2025-03-034Davidson Lisa — Chief Financial OfficerGrant/award (A): 174,700 (derivative) @ $0 · Grant/award (A): 91,500 (derivative) @ $0EDGAR
2025-03-034Rajagopalan Harith — Chief Executive Officer, DirectorGrant/award (A): 571,491 (derivative) @ $0 · Grant/award (A): 261,540 (derivative) @ $0EDGAR
2025-03-034Caplan Jay David — President, Chief Product Off.Grant/award (A): 179,700 (derivative) @ $0 · Grant/award (A): 104,400 (derivative) @ $0EDGAR
2025-02-034Rajagopalan Harith — Chief Executive Officer, DirectorOption exercise (M): 20,948 @ $1.70 · Sale (S): 20,948 @ $1.95 · Option exercise (M): 90,972 @ $1.70 · Sale (S): 90,972 @ $1.82 · Option exercise (M): 20,948 (derivative) @ $0 · Option exercise (M): 90,972 (derivative) @ $0EDGAR
2025-02-034Caplan Jay David — President, Chief Product Off.Option exercise (M): 21,472 @ $1.70 · Sale (S): 21,472 @ $1.95 · Option exercise (M): 22,346 @ $1.70 · Sale (S): 22,346 @ $1.81 · Option exercise (M): 21,472 (derivative) @ $0 · Option exercise (M): 22,346 (derivative) @ $0EDGAR
2024-11-134Rajagopalan Harith — Chief Executive Officer, DirectorOption exercise (M): 216,924 @ $0 · Sale (S): 96,517 @ $2.47 · Option exercise (M): 216,924 (derivative) @ $0EDGAR
2024-11-134Caplan Jay David — President, Chief Product Off.Option exercise (M): 187,257 @ $0 · Sale (S): 64,197 @ $2.47 · Option exercise (M): 187,257 (derivative) @ $0EDGAR
2024-09-134Caplan Jay David — President, Chief Product Off.Option exercise (M): 95,484 @ $1.70 · Sale (S): 65,000 @ $2.90 · Option exercise (M): 95,484 (derivative) @ $0EDGAR
2024-04-024Kimber Adrian — Chief Commercial OfficerGrant/award (A): 250,000 (derivative) @ $0EDGAR
2024-02-084Elia Marc — Director
M28 Capital Management LP — Director
Conversion (C): 1,389,451 · Purchase (P): 466,666 @ $15 · Conversion (C): 2,981,763 (derivative)EDGAR
2024-02-084Caplan Jay David — President, Chief Product Off.Conversion (C): 23,299 · Conversion (C): 118,810 · Conversion (C): 50,000 (derivative) · Conversion (C): 177,726 (derivative) · Conversion (C): 44,730 (derivative) · Conversion (C): 32,514 (derivative)EDGAR
2024-02-084General Catalyst GP V, LLC — 10% owner
General Catalyst Partners V, L.P. — 10% owner
General Catalyst Group V LP — 10% owner
GC Entrepreneurs Fund V, LP — 10% owner
Conversion (C): 4,702,161 · Conversion (C): 98,149 · Conversion (C): 3,204,832 (derivative) · Conversion (C): 66,897 (derivative) · Conversion (C): 3,098,678 (derivative) · Conversion (C): 64,681 (derivative) · +8 moreEDGAR
2024-02-084Bessemer Venture Partners VII L.P. — 10% owner
Bessemer Venture Partners VII Institutional L.P. — 10% owner
BVP VII SPECIAL OPPORTUNITY FUND LP — 10% owner
Deer VII & Co. L.P. — 10% owner
Deer VII & Co. Ltd. — 10% owner
Conversion (C): 4,770,901 · Conversion (C): 1,953,271 (derivative) · Conversion (C): 3,161,709 (derivative) · Conversion (C): 2,236,537 (derivative) · Conversion (C): 1,625,698 (derivative) · Conversion (C): 908,998 (derivative) · +1 moreEDGAR
2024-02-084Mithril LP — 10% owner
Mithril II UGP LLC — 10% owner
Mithril II GP LP — 10% owner
MITHRIL II LP — 10% owner
Mithril GP LP — 10% owner
THIEL PETER — 10% owner
Conversion (C): 5,160,301 · Conversion (C): 918,567 · Purchase (P): 333,333 @ $15 · Conversion (C): 4,025,764 (derivative) · Conversion (C): 6,502,796 (derivative) · Conversion (C): 545,450 (derivative) · +2 moreEDGAR
2024-02-084MEANWELL CLIVE — DirectorConversion (C): 277,890 · Conversion (C): 596,352 (derivative)EDGAR
2024-02-084Flynn James E — 10% owner
Deerfield Mgmt III, L.P. — 10% owner
Deerfield Private Design Fund III, L.P. — 10% owner
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — 10% owner
Conversion (C): 757,548 · Conversion (C): 76,706 · Conversion (C): 1,625,699 (derivative) · Conversion (C): 164,612 (derivative)EDGAR

Recent 8-K events — FRACTYL HEALTH, INC.

FiledFormItems reportedSource
2026-09-118-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-08-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-158-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-118-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-06-048-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-118-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-248-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-178-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-02-268-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=GUTS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →